Core Laboratories Inc.
US ˙ NYSE ˙ US21867A1051

SecurityCLB / Core Laboratories Inc.
InstitutionParallel Advisors, LLC
Latest Disclosed Ownership1,063 shares
Latest Disclosed Value $ 17,040
Parallel Advisors, LLC ownership in CLB / Core Laboratories Inc.

On February 11, 2026 - Parallel Advisors, LLC filed a 13F-HR form disclosing ownership of 1,063 shares of Core Laboratories Inc. (US:CLB) valued at $17,040 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 942 shares of Core Laboratories Inc.. This represents a change in shares of 12.85% during the quarter. The current value of the position is $14,202 USD.

Parallel Advisors, LLC has a history of taking positions in derivatives of the underlying security (CLB) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CLB / Core Laboratories Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F CORE LABORATORIES Stock 21867A105 1,063 121 12.85 17 54.55 0.0003
2025-11-13 2025-09-30 13F CORE LABORATORIES Stock 21867A105 942 427 82.91 12 120.00 0.0002
2025-07-08 2025-06-30 13F CORE LABORATORIES Stock 21867A105 515 -1,189 -69.78 6 -80.00 0.0001
2025-04-08 2025-03-31 13F CORE LABORATORIES Stock 21867A105 1,704 519 43.80 26 25.00 0.0006
2025-02-10 2024-12-31 13F CORE LABORATORIES Stock 21867A105 1,185 -93 -7.28 21 -13.04 0.0005
2024-11-13 2024-09-30 13F CORE LABORATORIES Stock 21867A105 1,278 31 2.49 24 -8.00 0.0006
2024-08-08 2024-06-30 13F CORE LABORATORIES Stock 21867A105 1,247 134 12.04 25 31.58 0.0006
2024-05-06 2024-03-31 13F CORE LABORATORIES Stock 21867A105 1,113 -241 -17.80 19 -17.39 0.0005
2024-02-12 2023-12-31 13F CORE LABORATORIES Stock 21867A105 1,354 112 9.02 24 -20.69 0.0007
2024-05-20 2023-09-30 13F/A-1 CORE LABORATORIES Stock 21867A105 1,242 0 0.00 30 3.57 0.0010
2023-11-14 2023-09-30 13F CORE LABORATORIES Stock 21867A105 1,242 0 30 0.0010
2024-05-20 2023-06-30 13F/A-1 CORE LABORATORIES Stock 21867A105 1,242 -33 -2.59 29 0.00 0.0009
2023-08-04 2023-06-30 13F CORE LABORATORIES Stock 21867A105 1,242 -33 29 0.0009
2024-05-20 2023-03-31 13F/A-1 CORE LABORATORIES Stock N22717107 1,275 0 0.00 28 12.00 0.0009
2023-04-25 2023-03-31 13F CORE LABORATORIES Stock N22717107 1,275 0 28 0.0009
2023-02-06 2022-12-31 13F CORE LABORATORIES Stock N22717107 1,275 69 5.72 26 56.25 0.0011
2022-11-10 2022-09-30 13F CORE LABORATORIES Stock N22717107 1,206 404 50.37 16 0.00 0.0007
2022-08-01 2022-06-30 13F CORE LABORATORIES Stock N22717107 802 -149 -15.67 16 -48.39 0.0007
2022-04-28 2022-03-31 13F CORE LABORATORIES Stock N22717107 951 95 11.10 31 63.16 0.0012
2022-01-20 2021-12-31 13F CORE LABORATORIES Stock N22717107 856 196 29.70 19 5.56 0.0007
2021-11-02 2021-09-30 13F/A-1 CORE LABORATORIES Stock N22717107 660 0 0.00 18 -30.77 0.0007
2021-08-06 2021-06-30 13F CORE LABORATORIES Stock N22717107 660 0 0.00 26 36.84 0.0011
2021-04-23 2021-03-31 13F CORE LABORATORIES Stock N22717107 660 0 0.00 19 11.76 0.0009
2021-02-02 2020-12-31 13F CORE LABORATORIES Stock N22717107 660 -476 -41.90 17 0.00 0.0009
2020-10-27 2020-09-30 13F CORE LABORATORIES Stock N22717107 1,136 -372 -24.67 17 -43.33 0.0011
2020-07-16 2020-06-30 13F CORE LABORATORIES Stock N22717107 1,508 645 74.74 30 275.00 0.0020
2020-04-27 2020-03-31 13F CORE LABORATORIES Stock N22717107 863 608 238.43 8 -20.00 0.0006
2020-01-30 2019-12-31 13F CORE LABORATORIES Stock N22717107 255 -1,579 -86.10 10 -88.37 0.0008
2019-11-01 2019-09-30 13F CORE LABORATORIES Stock N22717107 1,834 24 1.33 86 -9.47 0.0074
2019-08-05 2019-06-30 13F CORE LABORATORIES Stock N22717107 1,810 -154 -7.84 95 -29.63 0.0093
2019-05-01 2019-03-31 13F CORE LABORATORIES Stock N22717107 1,964 200 11.34 135 28.57 0.0152
2019-02-05 2018-12-31 13F CORE LABORATORIES Stock N22717107 1,764 130 7.96 105 -44.44 0.0146
2018-11-01 2018-09-30 13F CORE LABORATORIES Stock N22717107 1,634 691 73.28 189 58.82 0.0235
2018-07-30 2018-06-30 13F CORE LABORATORIES Stock N22717107 943 0 0.00 119 16.67 0.0170
2018-05-08 2018-03-31 13F CORE LABORATORIES Stock N22717107 943 0 0.00 102 -0.97 0.0159
2018-02-13 2017-12-31 13F CORE LABORATORIES N V COM Stock N22717107 943 0 0.00 103 5.10 0.0169
2017-11-15 2017-09-30 13F/A-1 CORE LABORATORIES N V COM Stock N22717107 943 -65 -6.45 98 -2.97 0.0169
2017-08-07 2017-06-30 13F CORE LABORATORIES N V COM Stock N22717107 1,008 117 13.13 101 0.00 0.0190
2017-05-12 2017-03-31 13F/A-1 CORE LABORATORIES N V COM Stock N22717107 891 223 33.38 101 26.25 0.0201
2017-05-12 2017-03-31 13F CORE LABORATORIES N V COM Stock N22717107 891 101
2017-02-14 2016-12-31 13F CORE LABORATORIES N V COM Stock N22717107 668 668 80 0.0188
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-01-19 2021-12-31 13F CORE LABORATORIES Stock Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-22 2021-09-30 13F CORE LABORATORIES Stock Call 660 26 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.